Corbus Pharma (CRBP) Advances to Session High, Up 33%

October 5, 2016 11:36 AM EDT
Get Alerts CRBP Hot Sheet
Trade CRBP Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Corbus Pharma (NASDAQ: CRBP) hit session highs heading into mid-day, extending gains after Cantor initiated coverage on the stock with a Buy rating and a price target of $17.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Trader Talk

Add Your Comment